[XENE] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
09-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -28.24%
YoY- -32.93%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 9 3,737 5,150 3,329 6,000 16 376 -46.30%
PBT -36,256 -25,080 -12,337 -11,412 -8,558 -8,065 -6,004 34.92%
Tax 1,139 484 -14 -36 357 14 542 13.16%
NP -37,395 -25,564 -12,323 -11,376 -8,558 -8,065 -6,004 35.62%
Tax Rate - - - - - - - -
Total Cost 37,404 29,301 17,473 14,705 14,558 8,081 6,380 34.26%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -426,591.38 -684.08 -239.28 -341.72 -142.63 -50,406.25 -1,596.81 153.67%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.57 -0.62 -0.35 -0.34 -0.34 -0.45 -0.33 9.53%
EPS Diluted -0.57 -0.62 -0.33 -0.34 -0.33 -0.45 -0.33 9.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.